SARS-CoV-2 related pneumonia in an adult with cystic fibrosis: natural favourable clinical course or effective therapy?
| Autor: | Maddalena Giglia, Giacomo Beci, Elena Rosselli Del Turco, Viola Guardigni, Alberto Amedeo, Giulia Cucchetto, Gabriella Verucchi, Marco Cipolli, Leonardo Calza, Pierluigi Viale |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: | |
| Zdroj: | Monaldi Archives for Chest Disease, Vol 90, Iss 4 (2020) |
| Druh dokumentu: | article |
| ISSN: | 1122-0643 2532-5264 |
| DOI: | 10.4081/monaldi.2020.1579 |
| Popis: | We report the case of a man affected by cystic fibrosis who developed a severe SARS-CoV-2 related pneumonia in March 2020. In addition to lopinavir/ritonavir and hydroxychloroquine, he was treated with two doses of tocilizumab, displaying a significant clinical improvement. This is the first case described in the literature of an adult patient affected by cystic fibrosis who received tocilizumab for COVID-19, with documented total recovery, also assessed by a spirometry. |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|